TACC3
MOLECULAR TARGETtransforming acidic coiled-coil containing protein 3
TACC3 (transforming acidic coiled-coil containing protein 3) is targeted by 7 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TACC3
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Aminoimidazole Carboxamide | 1.10 | 2 |
| 2 | Histamine | 1.10 | 2 |
| 3 | cefaclor | 0.69 | 1 |
| 4 | Cefdinir | 0.69 | 1 |
| 5 | Oxytetracycline | 0.69 | 1 |
| 6 | streptonigrin | 0.69 | 1 |
| 7 | Thioridazine | 0.69 | 1 |
About TACC3 as a Drug Target
TACC3 (transforming acidic coiled-coil containing protein 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 7 compounds with documented TACC3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TACC3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.